PROGRAMME. PUBLIC-PRIVATE INVESTMENT PARTNERSHIPS: Innovations for Quality and Efficiency in Health Systems

Transcription

1 PROGRAMME PUBLIC-PRIVATE INVESTMENT PARTNERSHIPS: Innovations for Quality and Efficiency in Health Systems Monday 20 to Wednesday 22 September th WILTON PARK CONFERENCE Organized by: The Global Health Group, UCSF The Healthcare Redesign Group Sponsored by: Bupa PricewaterhouseCoopers Ministry of Foreign Affairs, Netherlands RTT International Eversheds LLP This conference builds on the very successful high-level meeting held at Wilton Park in April 2008 which explored strategic opportunities for the private sector to support governments in strengthening health systems through longterm investment and commitment. The 2008 Meeting developed the model of Public-Private Investment Partnerships (PPIPs) that go beyond private investment in hospital buildings and maintenance, as typified by the UK s Private Finance Initiatives (PFIs), or the contracting out of selected services to the private sector, which is common in many countries. PPIPs encompass private capital investment, service model innovation, and delivery. They typically access private capital for infrastructure development in hospitals, clinics and other programs, and take this a step further to include ongoing private provision of clinical and support services. While PPIPs in the delivery of health services are the most common, the model can also be used to support governments in strengthening their capacity in health financing and purchasing. In this way, they bring in private sector expertise to work as long-term partners with governments, to build capacity and strengthen health systems for large portions of the population; not just those who can afford private care. The 2008 Meeting generated considerable interest among participants and countries at all income levels, and was followed by several country-level meetings, and a regional conference in Lesotho. The meeting also catalyzed development of a publication on PPIPs which is being followed by a more comprehensive compendium on PPIPs around the world.

2 The Conference The purpose of this Conference is to promote a better understanding of the needs of governments and private sector partners in the process of identifying, evaluating, and embarking on PPIP projects. Specifically the Conference will: 1. Bring together health and finance policy makers from a wide range of countries and potential private sector partners; to explore in greater depth the potential of PPIPs, and the processes which support PPIP development. 2. Bring in internationally recognized technical advisors to facilitate discussions on the various aspects of PPIP development including: a. Assessment of Opportunities: When is a PPIP the best solution? How to define a viable project that can serve the population for the next several decades. What types of projects lend themselves to these arrangements? How can value for money be assessed? b. Funders and Commercial Contracting: What do funders expect from governments and private partners to consider PPIP investments? What risk mitigation strategies can be included in contracts to encourage funders to invest in PPIPs in developing countries or underserved areas? Who are the likely consortia of funders for PPIPs in developing countries? c. Legal Aspects of Contract Development: What is the devil-in-detail in PPIP contracts? What are the legal implications of contracts between governments and non-state actors? How can commercial interests be protected, while promoting transparency? d. Setting Performance Standards in the Partnership: What really needs to be measured? How to mutually establish and monitor standards for clinical quality, effectiveness and efficiency. How to create a performance measurement system that is not too burdensome to administer. e. Getting from Financial Closure to Serving Patients: What can go wrong and how to avoid it. How should the implementation phase be monitored to ensure timely completion on agreed standards? What monitoring mechanisms are most effective? What capabilities must exist in the public sector to ensure success of PPIP arrangements over the long term? f. Evaluation of PPIPs: What does success look like? How to set up independent, objective evaluation of PPIPs which measures impact and helps to structure future projects. How to build in impact evaluation from the beginning to gather better data and promote improvement in design and implementation. 3. Explore the potential for ongoing collaboration to facilitate international learning on PPIPs and crosscountry, cross-regional sharing of PPIP evidence and information.

3 PUBLIC-PRIVATE INVESTMENT PARTNERSHIPS: Innovations for Quality and Efficiency in Health Systems MONDAY 20 SEPTEMBER Participants Arrive Buffet lunch available INTRODUCTION TO THE CONFERENCE Robin HART Director for Programmes, Wilton Park SETTING THE GLOBAL CONTEXT Chair: Robin HART Director for Programmes, Wilton Park The Role of Public-Private Partnerships in Today s Global Economy Lord HUTTON Adviser, Eversheds, London Tea/Coffee CREATING A PPIP: WHAT DOES IT TAKE? Chair: José CARBAJO Associate Director, Frontier Economics Ltd, London Neelam SEKHRI FEACHEM Chief Executive Officer, The Healthcare Redesign Group Inc, Alameda Alun COLE Senior Partner, Eversheds LLP, Cardiff Paul DA RITA Director, Corporate Finance, PricewaterhouseCoopers, London 1900 Drinks Reception 1930 Dinner

4 TUESDAY 21 SEPTEMBER INNOVATIONS IN HEALTH CARE DELIVERY Chair: HRH Prince Seeiso Bereng SEEISO High Commissioner for the Kingdom of Lesotho, London José Luis PARDO Director of Hospitals, Adeslas, Valencia Gabriela PUEYO Finance Director, Sanitas Bupa, Madrid Victor LITLHAKANYANE Executive Director for Stakeholder Relations, Netcare; Lesotho and South Africa, Johannesburg Photograph and Tea/Coffee INNOVATIONS IN SUPPLIES AND PHARMACEUTICALS Lunch Chair: Paul MILLIGAN Executive General Manager, International Public Private Partnerships, Hospital and Healthcare Solutions, GE Healthcare, Little Chalfont Peter MWABA Permanent Secretary, Ministry of Health, Lusaka Iain BARTON Executive Director, The RTT (Pty) Group, Boksburg Garden Tour (optional) INNOVATIONS IN HEALTH FINANCING AND INSURANCE Tea/Coffee Chair: Mark BASSETT Group Director of Public Policy, Bupa, London Onno SCHELLEKENS Managing Director, PharmAccess Foundation, Amsterdam Nathaniel OTOO Director, Administration and General Counsel, National Health Insurance Authority, Accra GETTING TO YES (OR LEADERSHIP COUNTS): POLITICS, STAKEHOLDERS AND EMPOWERMENT Chair: Christine BENNETT Chief Medical Officer, Bupa Australia Group, Sydney Fraser NIHORYA Deputy Minister of Finance, Ministry of Finance, Lilongwe Alfonso BATALLER VICENT Deputy Health Minister, Department of Health, Regional Government of Valencia, Valencia

5 GETTING THE DEAL RIGHT Chair: David HARRISON Independent Consultant, Associate with Infrastructure UK, Bedford Ian WOOTTON Partner, PricewaterhouseCoopers LLP, London David PITTS Director, International Development Group, Standard Bank PLC, London Wael Fayek SALEH Senior Investment Officer Health, African Development Bank, Tunis Boris MARTOR Partner, Eversheds LLP, Paris 1930 Drinks Reception 2000 Sponsors Dinner hosted by Richard Burge, Chief Executive, Wilton Park WEDNESDAY 22 SEPTEMBER CATALYZING INNOVATION AND ACTION I: Tea/Coffee Chair: Lord BOATENG Member, House of Lords; Former Chief Secretary to HM Treasury; Former British High Commissioner to South Africa and Lesotho, London Gavin MCGILLIVRAY Head, Global Funds and Development Finance Institutions, Department for International Development, London Karen CAVANAUGH Health Science Specialist, Global Health Initiative Launch Team, US Agency for International Development, Washington DC Kei KAWABATA Manager, Social Sector, Inter-American Development Bank, Washington DC CATALYZING INNOVATION AND ACTION II: Chair: Lord BOATENG Member, House of Lords; Former Chief Secretary to HM Treasury; Former British High Commissioner to South Africa and Lesotho, London Edit VELÉNYI Health Economist, Development Economics Operations and Strategy, World Bank, Washington DC Keith PALMER Founder Chairman, Emerging Africa Infrastructure Fund; Founder and Chairman, Cambridge Economic Policy Associates; Founder and Chairman, InfraCo Ltd, London CONCLUDING DISCUSSION Lunch 1400 Participants depart after lunch